Part 6/8:
A month post-discontinuation, alarming findings emerged from a study indicating that rapamycin may actually accelerate biological aging across multiple epigenetic clocks in humans. The narrative concluded with an ironic twist: the very drug intended to combat aging was implicated in its acceleration.
This irony was not lost on the narrator, who reflected on the humor inherent in the scientific journey. The results compelled a recognition that science is fraught with unexpected outcomes and that the process of discovery often involves risk, trial, and error.